Denver Carter, DPM
Podiatrist · Magee, MSNPI 1497827695
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $271 of the $342 with a category attached, or 79.2%. 9 manufacturers reported payments, led by Organogenesis Inc. at 30.1% of the total. Reporting peaked in 2024 at $131 and has fallen 78.1% since, to $29 in 2025. That places this record below the midpoint for podiatrist clinicians in MS, where the typical reported total is $566.
Across 12 payments — averaging $28.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$103
- Rikco International, LLC$71
- Averitas Pharma Inc.$48
- Treace Medical Concepts, Inc.$32
- Smith+Nephew$25
- DJO, LLC$22
- plus $41 from 3 others
What the payments were for
- Food & beverage$27179%
- Education$7121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 2 | $103 |
| Rikco International, LLC | 1 | $71 |
| Averitas Pharma Inc. | 2 | $48 |
| Treace Medical Concepts, Inc. | 1 | $32 |
| Smith+Nephew | 2 | $25 |
| DJO, LLC | 1 | $22 |
| Inari Medical, Inc. | 1 | $18 |
| Merck | 1 | $12 |
| Biowound Solutions, Inc. | 1 | $10 |
How this compares
$342 in reported general payments places this provider in the 40th percentile of 28 podiatrist providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 295 | $3,777 |
| Pregabalin | 84 | $1,713 |
| Terbinafine Hcl | 170 | $901 |
| Ciclopirox | 31 | $653 |
| Diclofenac Sodium | 28 | $463 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $458 |
| Doxycycline Hyclate | 34 | $308 |
| Methylprednisolone | 14 | $134 |
| Cephalexin | 16 | $121 |
| Colchicine | 12 | $94 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $89 |
| Meloxicam | 41 | $86 |
| Amoxicillin | 28 | $58 |
| Triamcinolone Acetonide | 14 | $53 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Magee
- Carla MartinOlive Branch$9K
- Shelley BrandWaynesboro$7K
- Clint JirouxNew Albany$2K
- Percy AndersonJackson$2K
- Rose SotolongoRidgeland$2K
- Carey WilliamsOxford$2K
- Elizabeth TiceJackson$2K
- Stefanie ThomasClinton$2K
- Mohammad ParsaMadison$1K
- Gerard GuerinBiloxi$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.